- Generated $1.1M in revenue in Q3-FY2021 (quarter end April 30, 2021), up 24% YoY, and up 8.6% QoQ. 98% of revenue came from dried flower sales. Revenue was significantly below our expectations as the company has yet to start generating meaningful revenue from its 2.0 products (edibles and beverages).
- To read more about THC BioMed Intl Ltd. click below on downloads
Visit THC BioMed Intl Ltd. page for more research, discussion boards and to like, and share.
Download Analyst Report :
Investors are also interested in:
TAAT Global Alternatives Inc. (CSE: TAAT / OTCQX: TOBAF / FRA: 2TP)Marketing Dollars Driving Strong Sales Growth